Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2026-02-21 @ 9:06 PM
Study NCT ID:
NCT02306850
Status:
COMPLETED
Last Update Posted:
2019-06-20
First Post:
2014-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma
Sponsor:
Organization: